Sphere Medical Holding (SPHR)
Wolfgang Rencken, CEO
ShareSoc Growth Company Seminar 21st October 2015
Wolfgang outlines the role of their Proxima blood gas analyser to optimise the most efficient patient flow through hospitals.
Wolfgang Rencken sees the global market potential as $200m.
SPHR are well capitalised from a fund raise of £13.2m including £4m from Woodford
The next stage is to find a partner – an existing company with an international sales team, selling Proxima 4 into hospitals.
Hospital’s reluctance to change procedures is the biggest challenge to SPHR’s commercialisation. It will take time, but ultimately, if that resistance is broken down the potential is huge.
Presentation slides can be viewed here (a new window will open).
PIWORLD provides investors with the latest news and insight to listed companies and their management teams through either live or recorded results presentations, corporate overviews, management interviews and Capital Market Days. Together with interviews from leading fund managers, market specialists and esteemed private investors, we aim to keep the private investor community up to date and informed.
PIWORLD delivers high quality audio and video content to present anything from full-year and interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.
